F

Forte Biosciences

FBRX

0.54380

USD

-0.0321

(-5.57%)

Market Closed

Volume

32

EPS

0

Div Yield

0

P/E

-0

Market Cap

6,088,855

Overview Signals Ideas News

Related Instruments

A

-0.440

(-1.61%)

26.860 USD

A

31.19

(13.13%)

268.66 USD

A

-0.250

(-2.37%)

10.290 USD

B

0.270

(0.32%)

84.620 USD

I

-0.680

(-1.05%)

64.390 USD

I

1.830

(3.70%)

51.330 USD

R

1.230

(1.09%)

113.430 USD

S

1.650

(1.16%)

144.000 USD

9.75

(1.97%)

505.40 USD

Orange Juice Prices Soar, and May Stay That Way

3 months ago

Tech Stocks Fall on Nasdaq’s Worst Day Since 2022

3 months ago

EV Maker Fisker Files for Bankruptcy

4 months ago

Novo Nordisk Surges in Profit and Sales

5 months ago

Meta Stock Plunges as Company Promises AI Splurge

6 months ago

Title: Forte Biosciences Inc

Sector: Healthcare

Industry: Biotechnology

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indicationsas graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).